Novel modeling framework to guide design of optimal dosing strategies for β-lactamase inhibitors (Q35941209)

11 August 2017

Novel modeling framework to guide design of optimal dosing strategies for β-lactamase inhibitors (English)

1 reference

11 August 2017

Pratik Bhagunde

1

1 reference

11 August 2017

Kai-Tai Chang

2

1 reference

11 August 2017

Elizabeth B Hirsch

3

1 reference

11 August 2017

Kimberly R Ledesma

4

1 reference

11 August 2017

Michael Nikolaou

5

1 reference

11 August 2017

Vincent H Tam

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

13 February 2012

1 reference

Antimicrobial Agents and Chemotherapy

11 August 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 August 2017

56

1 reference

11 August 2017

2237-2240

1 reference

11 August 2017

5

1 reference

A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346582

Three decades of beta-lactamase inhibitors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346582

Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346582

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346582

Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346582

Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346582

Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346582

Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3346582

Pharmacokinetics of imipenem in healthy volunteers

14 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22330927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Bacterial-population responses to drug-selective pressure: examination of garenoxacin's effect on Pseudomonas aeruginosa

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22330927

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.06113-11

1 reference

11 August 2017

1 reference

11 August 2017

1 reference